EP Patent

EP0237506A1 — Pharmaceutical composition

Assigned to Lejus Medical AB · Expires 1987-09-16 · 39y expired

What this patent protects

The present invention relates to a process for preparing a rapidly disintegrating core granulate containing a pharma­ceutically active compound, whioh granulate is optionally intended to be coated with a release determining coating, as well as such cores, whereby one adds a pharm…

USPTO Abstract

The present invention relates to a process for preparing a rapidly disintegrating core granulate containing a pharma­ceutically active compound, whioh granulate is optionally intended to be coated with a release determining coating, as well as such cores, whereby one adds a pharmaceutically active compound, optionally together with an emulsifier, to a solvent, and optionally treats the composition obtained intensively, optionally while reducing its particle size, distributes the treated composition obtained over a bed of a solid, preferably water soluble material, and dries the agglomerates thus obtained to the formation of a rapidly disintegrating core granulate.

Drugs covered by this patent

Patent Metadata

Patent number
EP0237506A1
Jurisdiction
EP
Classification
—
Expires
1987-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Lejus Medical AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.